Teva Pharmaceutical captured 20 percent of a German insurer's recent tender, just one of several in coming months that the company hopes to use to penetrate the German generics market. Release [1]
Links:
[1] http://www.fiercebiotech.com/press-releases/teva-receives-positive-results-aok-tender